Doloneuro-Tropas

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, rheumatism, arthritis, inflammation, and general pain.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are advised to take 2 tablets orally every 6 hours. The total daily dosage should not exceed 6 tablets within a 24-hour period. For children under 12 years of age, it is recommended to consult a physician for appropriate dosing guidance. It is imperative that the recommended dosage is not exceeded to ensure safety and efficacy.

Contraindications

Use of this product is contraindicated in patients who are concurrently taking any other drug containing acetaminophen, whether prescription or nonprescription. Due to the potential for acetaminophen overdose, it is essential to consult a healthcare professional, such as a doctor or pharmacist, before combining this product with any other medications.

Warnings and Precautions

Severe liver damage may occur with the use of this product, which contains acetaminophen. Healthcare professionals should advise patients to adhere strictly to the following guidelines to mitigate the risk of liver injury:

• Patients must not exceed 6 tablets within a 24-hour period, as this is the maximum daily dosage.

• Caution is advised against the concurrent use of other medications that also contain acetaminophen.

• Patients should limit alcohol consumption to fewer than 3 drinks per day while using this product, as increased alcohol intake can exacerbate the risk of liver damage.

In addition to the liver warning, healthcare professionals should be aware of the caffeine content in this product. The recommended dosage is comparable to that found in a standard cup of coffee. Therefore, it is prudent to limit the intake of other caffeine-containing medications, foods, or beverages during treatment. Excessive caffeine consumption may lead to adverse effects such as nervousness, irritability, sleeplessness, and, in some cases, rapid heartbeat. Monitoring for these symptoms is advisable to ensure patient safety and comfort.

Side Effects

Patients using this product should be aware of potential adverse reactions associated with its use, particularly concerning liver and caffeine-related warnings.

Severe liver damage may occur if patients exceed the maximum recommended dosage of 6 tablets in a 24-hour period, take this product in conjunction with other medications containing acetaminophen, or consume 3 or more alcoholic drinks daily while using this product. It is crucial for patients to adhere strictly to the dosing guidelines to mitigate the risk of liver injury.

Additionally, the product contains a caffeine content comparable to that of a standard cup of coffee. Patients are advised to limit the intake of other caffeine-containing medications, foods, or beverages during treatment, as excessive caffeine consumption may lead to symptoms such as nervousness, irritability, sleeplessness, and, in some cases, rapid heartbeat.

These warnings highlight the importance of careful monitoring of both liver function and caffeine intake while using this product to ensure patient safety and minimize the risk of adverse reactions.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Doloneuro-Tropas (acetaminophen, caffeine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents aged 12 years and older, the recommended dosage is 2 tablets every 6 hours, with a maximum of 6 tablets in a 24-hour period.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population, given the lack of targeted data.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the drug insert. Healthcare professionals should exercise caution when prescribing this medication to patients with renal impairment, as the absence of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical for patients to adhere to the following guidelines to minimize the risk of hepatotoxicity:

• The maximum recommended dosage is 6 tablets within a 24-hour period. Exceeding this limit may lead to severe liver damage.

• Patients should avoid concomitant use of other medications that contain acetaminophen, as this can further increase the risk of liver injury.

• Consumption of 3 or more alcoholic drinks daily while using this product is contraindicated, as it may exacerbate the potential for liver damage.

Patients with a history of liver disease are advised to consult a healthcare professional prior to using this product to ensure safe and appropriate use. Regular monitoring of liver function may be warranted in patients with compromised liver function to detect any potential adverse effects promptly.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt medical intervention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals should be aware that the lack of immediate symptoms does not preclude the potential for serious health consequences. Therefore, vigilance and timely action are essential in managing overdose situations effectively.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use. There are no specific non-teratogenic effects or nonclinical toxicology details available. Additionally, no specific information regarding animal pharmacology and toxicology has been provided.

Postmarketing Experience

No specific postmarketing experience details are available. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center (1-800-222-1222) in the event of an overdose. It is crucial to emphasize that prompt medical attention is necessary for both adults and children, even if no signs or symptoms are initially apparent.

Patients should be informed not to use this medication in conjunction with any other products containing acetaminophen, whether prescription or nonprescription. It is recommended that patients consult with a doctor or pharmacist before using this medication alongside any other drugs if they are uncertain.

Healthcare providers should instruct patients to discontinue use and consult a doctor if any new symptoms arise. Additionally, patients should be advised to stop using the medication and seek medical advice if their symptoms do not improve or if they worsen. It is important to inform patients to stop use and contact a doctor if the area experiencing pain becomes red or swollen, if the pain intensifies, or if it persists for more than 10 days. Furthermore, patients should be cautioned to stop use and consult a doctor if a fever worsens or lasts longer than 3 days.

Patients with a history of liver disease should be advised to consult a doctor before using this medication. Lastly, it is essential to recommend that patients taking the blood-thinning medication warfarin speak with a doctor or pharmacist prior to use.

Storage and Handling

The product is supplied in a configuration that ensures tamper evidence. It is imperative to inspect the safety seal under the cap; the product should not be used if the seal is broken or missing.

For optimal storage, the product must be kept at a controlled room temperature ranging from 20° to 25°C (68° to 77°F). Proper handling and storage conditions are essential to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Doloneuro-Tropas, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)